Funded Tech Companies
Q32 Bio
Q32 Bio, operating out of Cambridge, received equity investments from OrbiMed, Osage University Partners and Acorn Bioventures.
Company Overview
Company Name
Q32 Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Bdwy. 11th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, to re-balance immunity in severe autoimmune and inflammatory diseases. Q32 Bio's lead programs, focused on the IL-7R pathway and complement system, address immune dysregulation to help patients take back control of their lives.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/25/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Broxson
Chief Scientific Officer
Shelia Violette
Vice President
Susan Kalled
VP - Bus. Development
Maria Marzilli
VP - Manufacturing
Kathryn Golden
VP - Operations
Charles Romano
Company Investors
- OrbiMed (Stephen Squinto)
- Osage University Partners
- Acorn Bioventures (Isaac Manke)
- Sanofi Ventures
- Agent Capital
- Atlas Venture (David Grayzel)
- Abingworth
- Bristol Myers Squibb
- CU Healthcare Innovation Fund
- Sanofi-Genzyme BioVentures
- Children's Hospital Colorado
- University of Colorado
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs